Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
3,285
Showing 50 of 3,285
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 101 | HTCR | Heartcore Enterprises, Inc. | 32 | 4 | 88% | +51.8% | +58.4% | +91.9% | -14.5% |
| 102 | MIRA | Mira Pharmaceuticals, Inc. | 60 | 4 | 92% | +51.7% | +59.3% | +81.7% | -87.3% |
| 103 | ICHR | Ichor Holdings, Ltd. | 25/37 | 12 | 72% | +51.0% | +33.1% | +366.1% | -27.5% |
| 104 | HWKN | Hawkins Inc | 17/19 | 3 | 100% | +50.8% | +56.1% | +60.8% | +6.3% |
| 105 | EAF | Graftech International Ltd | 1,285 | 28 | 99% | +50.7% | +52.6% | +61.9% | -47.5% |
| 106 | YBGJ | Yubo International Biotech Ltd | 19 | 3 | 100% | +50.4% | +49.3% | +69.6% | +49.3% |
| 107 | KALA | Kala Pharmaceuticals, Inc. | 93 | 14 | 85% | +49.5% | +70.3% | +88.8% | -67.5% |
| 108 | NPWR | Net Power Inc. | 171/249 | 9 | 98% | +49.5% | +52.7% | +88.1% | -33.2% |
| 109 | ASA | Asa Gold & Precious Metals Ltd | 183/227 | 6 | 99% | +48.3% | +37.3% | +111.5% | -41.0% |
| 110 | MYO | Myomo, Inc. | 42/52 | 9 | 64% | +48.2% | +22.2% | +271.6% | -81.2% |
| 111 | TENX | Tenax Therapeutics, Inc. | 15/17 | 6 | 100% | +48.1% | +51.2% | +58.7% | +17.1% |
| 112 | VOR | Vor Biopharma Inc. | 223/283 | 8 | 99% | +48.0% | +46.6% | +62.9% | -44.2% |
| 113 | MDRX | Veradigm Inc. | 118 | 15 | 94% | +47.9% | +59.1% | +63.6% | -10.1% |
| 114 | TERN | Terns Pharmaceuticals, Inc. | 120/131 | 20 | 53% | +47.6% | +29.9% | +1049.7% | -977.9% |
| 115 | APPS | Digital Turbine, Inc. | 32/33 | 8 | 59% | +47.5% | +43.2% | +283.5% | -56.7% |
| 116 | QTRX | Quanterix Corp | 53 | 10 | 96% | +47.0% | +52.6% | +70.7% | -41.4% |
| 117 | LBRX | Lb Pharmaceuticals Inc | 18 | 10 | 100% | +46.9% | +46.9% | +46.9% | +46.9% |
| 118 | LIFW | Msp Recovery, Inc. | 86/90 | 12 | 84% | +46.8% | +65.1% | +83.5% | -81.1% |
| 119 | IMMX | Immix Biopharma, Inc. | 30/32 | 7 | 73% | +46.4% | +11.0% | +449.5% | -56.7% |
| 120 | TRDA | Entrada Therapeutics, Inc. | 346/355 | 32 | 57% | +46.3% | +12.2% | +224.1% | -70.3% |
| 121 | UP | Wheels Up Experience Inc. | 24/29 | 15 | 88% | +46.1% | +69.8% | +88.3% | -100.0% |
| 122 | IAUX | I-80 Gold Corp. | 16/23 | 10 | 56% | +45.9% | +50.9% | +92.8% | -1.7% |
| 123 | NVAX | Novavax Inc | 24 | 5 | 100% | +45.9% | +52.2% | +72.8% | +21.6% |
| 124 | MNTN | Mntn, Inc. | 18 | 15 | 100% | +45.8% | +49.8% | +49.8% | +24.6% |
| 125 | VNO | Vornado Realty Trust | 45/50 | 4 | 98% | +45.7% | +60.4% | +68.3% | -40.4% |
| 126 | MILC | Millennium Sustainable Ventures Corp. | 15 | 4 | 60% | +45.6% | +99.5% | +99.6% | -81.0% |
| 127 | UMAC | Unusual MacHines, Inc. | 18/31 | 8 | 39% | +45.5% | -20.9% | +370.2% | -156.8% |
| 128 | LGCY | Legacy Education Inc. | 44/46 | 6 | 93% | +45.2% | +37.5% | +97.4% | -6.7% |
| 129 | RELI | Reliance Global Group, Inc. | 20/22 | 7 | 80% | +45.0% | +77.2% | +84.8% | -67.4% |
| 130 | FCUV | Focus Universal Inc. | 32 | 3 | 66% | +44.5% | +124.9% | +127.3% | -76.0% |
| 131 | VERA | Vera Therapeutics, Inc. | 155/170 | 23 | 75% | +44.5% | +39.6% | +166.5% | -148.1% |
| 132 | ALTO | Alto Ingredients, Inc. | 14/16 | 6 | 57% | +44.3% | +20.1% | +161.3% | -36.8% |
| 133 | CRMT | Americas Carmart Inc | 734/738 | 10 | 93% | +43.6% | +48.6% | +55.7% | -49.3% |
| 134 | COOK | Traeger, Inc. | 41 | 3 | 90% | +43.6% | +49.8% | +64.2% | -42.9% |
| 135 | SONO | Sonos Inc | 137/228 | 19 | 91% | +43.2% | +37.3% | +107.8% | -51.7% |
| 136 | PRME | Prime Medicine, Inc. | 266 | 23 | 89% | +42.6% | +45.8% | +227.9% | -45.0% |
| 137 | PBT | Permian Basin Royalty Trust | 56 | 4 | 100% | +42.3% | +42.6% | +58.8% | +31.7% |
| 138 | PEPG | Pepgen Inc. | 63/70 | 21 | 81% | +42.0% | +5.1% | +396.0% | -39.4% |
| 139 | MYSZ | My Size, Inc. | 19/20 | 5 | 74% | +41.7% | +72.3% | +77.8% | -45.8% |
| 140 | GDRX | Goodrx Holdings, Inc. | 59 | 9 | 100% | +41.7% | +42.9% | +80.0% | +21.4% |
| 141 | CBUS | Cibus, Inc. | 65/68 | 6 | 98% | +41.5% | +37.8% | +77.2% | -11.8% |
| 142 | SVRA | Savara Inc | 33/34 | 20 | 97% | +41.4% | +35.7% | +196.6% | -1.3% |
| 143 | HOWL | Werewolf Therapeutics, Inc. | 398/473 | 19 | 96% | +41.3% | +46.8% | +56.8% | -67.3% |
| 144 | LOCL | Local Bounti Corporation/De | 74/81 | 13 | 86% | +41.2% | +51.1% | +86.1% | -55.1% |
| 145 | GCO | Genesco Inc | 31 | 10 | 74% | +40.4% | +76.1% | +78.1% | -56.1% |
| 146 | JANX | Janux Therapeutics, Inc. | 256/263 | 16 | 88% | +40.3% | +34.9% | +605.1% | -42.7% |
| 147 | ANTX | An2 Therapeutics, Inc. | 190/200 | 21 | 72% | +40.2% | +75.8% | +175.0% | -325.4% |
| 148 | KZR | Kezar Life Sciences, Inc. | 24 | 5 | 75% | +39.9% | +64.6% | +70.0% | -41.4% |
| 149 | ZIVO | Zivo Bioscience, Inc. | 31/43 | 7 | 42% | +39.9% | -4.3% | +441.7% | -83.3% |
| 150 | BOXL | Boxlight Corp | 93 | 8 | 95% | +39.7% | +43.7% | +87.5% | -70.1% |